[D-dimer in diagnosis and treatment of pulmonary embolism].
Journal Title: Advances in Respiratory Medicine - Year 2009, Vol 77, Issue 3
Abstract
D-dimer level estimation, specific fibrin degradation product, is a permanent part of diagnostic strategies of pulmonary embolism (PE). Approximately 30% of a suspected non-high risk PE can be ruled out with high sensitive D-dimer test when pre-test clinical probability is non-high. Recent guidelines underline that only very sensitive DD assays can be used. The main limitation of DD tests is relatively low specificity especially in hospitalized population, in elder patients, with cancer and in pregnancy. New indication for DD test mentioned in current guidelines is estimation of risk of recurrence after withdrawal of anticoagulant. Negative DD test identify patients with low risk of recurrence.
Authors and Affiliations
Anna Fijałkowska
Sródmiazszowa choroba płuc w przebiegu niedoboru białka C surfaktantu współistniejacego z pierwotnym niedoborem odporności - opis przypadku.
Gastric sarcoidosis -- a case report
Gastrointestinal sarcoidosis is very rare manifestation of the illness. This article presents patient who had been diagnosed for several months because of abdominal pain, vomiting and significant weight loss. Numerous ga...
[The frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire].
Hypersensitivity reactions to drugs account for 25% of all side effects related to drugs, affecting more than 7% of the population. One in four such reactions is caused by acetylic acid and other non-steroidal anti-infla...
[Comparison of Th1 and Th2 response in the blood of tuberculous patients and healthy contacts].
Th1 response is known to play a dominant role in the resistance to tuberculosis. Nevertheless, IFN gamma levels are frequently increased in tuberculous patients, especially at the site of the disease. It is also possible...
Markery włóknienia i zapalenia w kondensacie powietrza wydychanego (EBC) oraz w płynie z płukania oskrzelowo-pecherzykowego (BALF) u chorych na sarkoidoze płuc - badanie pilotazowe.